Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5120036 | 6074967 | F | 1 | 5120036-5 | 20060531 | 20060918 | 20060929 | EXP | 2006072196 | PFIZER INC | 43 | YR | F | N | 54 | KG | 20060928 | MD | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5120036 | 1007726862 | PS | SUTENT | 1 | ORAL | 50 MG (50 MG, 4 WEEKS - INTERVAL: 2 WEEKS), ORAL | Y | D | 21938 | ||
| 5120036 | 1007745890 | C | URSODIOL (URSODEOXYCHOLIC ACID) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5120036 | 1007726862 | HEPATIC NEOPLASM MALIGNANT NON-RESECTABLE |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5120036 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5120036 | ANAEMIA |
| 5120036 | PELVIC PAIN |
| 5120036 | PERITONEAL EFFUSION |
| 5120036 | PERITONEAL HAEMORRHAGE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5120036 | FGN |
| 5120036 | HP |
| 5120036 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5120036 | 1007726862 | 20060505 | 20060601 |